Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

Syros Pharmaceuticals Inc (SYRS)

Syros Pharmaceuticals Inc (SYRS)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0269 +0.0069 (+34.50%) 04/17/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0269 unch (unch) 15:20 ET
Profile for Thu, Apr 17th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.

Company Info

Syros Pharmaceuticals Inc 35 Cambridge Park Drive 4th Floor CAMBRIDGE MA 02140 USA

www.syros.com Employees: 68 P: 617-744-1340

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Syros Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on treatments for cancer and immune-mediated diseases as well as building a pipeline of gene control medicines. The company's product pipeline includes SY-1425, a selective RARa agonist for genomically defined subsets of patients with relapsed or refractory acute myeloid leukemia and relapsed high-risk myelodysplastic syndrome and SY-1365, a selective CDK7 inhibitor for acute leukemia which is in preclinical stage. Syros Pharmaceuticals, Inc. is based in Cambridge, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 1,650
Enterprise Value, $K -96,650
Shares Outstanding, K 26,832
Annual Sales, $ 9,940 K
Annual Net Income, $ -164,570 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -6,400 K
EBIT, $ -111,660 K
EBITDA, $ -108,830 K
60-Month Beta 1.31
% of Insider Shareholders 12.26%
% of Institutional Shareholders 91.47%
Float, K 23,542
% Float 87.74%
Short Volume Ratio 0.01

Growth:

1-Year Return -56.26%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 384.88%
5-Year Earnings Growth 75.39%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.68 on 10/31/24
Next Earnings Date 03/26/25
Earnings Per Share ttm -3.36
EPS Growth vs. Prev Qtr 2.86%
EPS Growth vs. Prev Year 49.63%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 09/19/22

SYRS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -3,369.56%
Return-on-Assets % -97.04%
Profit Margin % -1,655.63%
Debt/Equity -3.69
Price/Sales 11.17
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.41
Interest Coverage -31.08
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro